Guanosine prevents behavioral alterations in the forced swimming test and hippocampal oxidative damage induced by acute restraint stress

Pharmacology Biochemistry and Behavior

Volumn 127, Issue , 2014, Pages 7-14

  Bettio, Luis E B ^a   Freitas, Andiara E ^a   Neis, Vivian B ^a   Santos, Danúbia B ^a   Ribeiro, Camille M ^a   Rosa, Priscila B ^a   Farina, Marcelo ^a   Rodrigues, Ana Lúcia S ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Acute restraint stress; Antidepressant; Antioxidant; Guanosine; Oxidative stress

Indexed keywords

CATALASE; FLUOXETINE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GUANOSINE; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BEHAVIOR CHANGE; BRAIN DAMAGE; CHEMICAL ANALYSIS; CLINICAL EVALUATION; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; FORCED SWIM TEST; HIPPOCAMPAL OXIDATIVE DAMAGE; IMMOBILITY; IMMOBILIZATION STRESS; LIPID PEROXIDATION; LOCOMOTION; MOUSE; NEUROPROTECTION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; ACUTE DISEASE; ANIMALS; DRUG EFFECTS; DRUG THERAPY; HIPPOCAMPUS; METABOLISM; MICE; OXIDATION-REDUCTION; PHYSIOLOGY; PSYCHOLOGY; RESTRAINT, PHYSICAL; STRESS, PSYCHOLOGICAL; SWIMMING;

ACUTE DISEASE; ANIMALS; FEMALE; GUANOSINE; HIPPOCAMPUS; MICE; OXIDATION-REDUCTION; OXIDATIVE STRESS; RESTRAINT, PHYSICAL; STRESS, PSYCHOLOGICAL; SWIMMING;

EID: 84908403693     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2014.10.002     Document Type: Article

References (81)

1. S. Aboul-Fotouh Coenzyme Q10 displays antidepressant-like activity with reduction of hippocampal oxidative/nitrosative DNA damage in chronically stressed rats Pharmacol Biochem Behav 104 2013 105 112
2. H. Aebi Catalase in vitro Methods Enzymol 105 1984 121 126
3. A. Ahmad, N. Rasheed, G.M. Ashraf, R. Kumar, N. Banu, and F. Khan Brain region specific monoamine and oxidative changes during restraint stress Can J Neurol Sci 39 2012 311 318
4. G.A. Behr, C.E. Schnorr, A. Simoes-Pires, L.L. da Motta, B.N. Frey, and J.C. Moreira Increased cerebral oxidative damage and decreased antioxidant defenses in ovariectomized and sham-operated rats supplemented with vitamin A Cell Biol Toxicol 28 2012 317 330
5. L.E. Bettio, M.P. Cunha, J. Budni, F.L. Pazini, A. Oliveira, and A.R. Colla Guanosine produces an antidepressant-like effect through the modulation of NMDA receptors, nitric oxide-cGMP and PI3K/mTOR pathways Behav Brain Res 234 2012 137 148
6. M. Bilici, H. Efe, M.A. Koroglu, H.A. Uydu, M. Bekaroglu, and O. Deger Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments J Affect Disord 64 2001 43 51
7. J. Budni, A.D. Zomkowski, D. Engel, D.B. Santos, A.A. dos Santos, and M. Moretti Folic acid prevents depressive-like behavior and hippocampal antioxidant imbalance induced by restraint stress in mice Exp Neurol 240 2013 112 121
8. I. Carlberg, and B. Mannervik Glutathione reductase Methods Enzymol 113 1985 484 490
9. H.E. Covington III, V. Vialou, and E.J. Nestler From synapse to nucleus: novel targets for treating depression Neuropharmacology 58 2010 683 693
10. J.F. Cryan, and C. Mombereau In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice Mol Psychiatry 9 2004 326 357
11. J.C. Capra, M.P. Cunha, D.G. Machado, A.D.E. Zomkowski, B.G. Mendes, and A.R.S. Santos Antidepressant-like effect of scopoletin, a coumarin isolated from Polygala sabulosa (Polygalaceae) in mice: evidence for the involvement of monoaminergic systems Eur J Pharmacol 643 2010 232 238
12. T. Dal-Cim, S. Molz, J. Egea, E. Parada, A. Romero, and J. Budni Guanosine protects human neuroblastoma SH-SY5Y cells against mitochondrial oxidative stress by inducing heme oxigenase-1 via PI3K/Akt/GSK-3beta pathway Neurochem Int 61 2012 397 404
13. E. Degenetais, A.M. Thierry, J. Glowinski, and Y. Gioanni Synaptic influence of hippocampus on pyramidal cells of the rat prefrontal cortex: an in vivo intracellular recording study Cereb Cortex 13 2003 782 792
14. T.B. Deramaudt, C. Dill, and M. Bonay Regulation of oxidative stress by Nrf2 in the pathophysiology of infectious diseases Med Mal Infect 43 2013 100 107
15. G.L. Ellman Tissue sulfhydryl groups Arch Biochem Biophys 82 1959 70 77
16. J. Fan, G. Xu, T. Jiang, and Y. Qin Pharmacologic induction of heme oxygenase-1 plays a protective role in diabetic retinopathy in rats Invest Ophthalmol Vis Sci 53 2012 6541 6556
17. F.U. Fontella, I.R. Siqueira, A.P. Vasconcellos, A.S. Tabajara, C.A. Netto, and C. Dalmaz Repeated restraint stress induces oxidative damage in rat hippocampus Neurochem Res 30 2005 105 111
18. A.E. Freitas, L.E. Bettio, V.B. Neis, D.B. Santos, C.M. Ribeiro, and P.B. Rosa Agmatine abolishes restraint stress-induced depressive-like behavior and hippocampal antioxidant imbalance in mice Prog Neuropsychopharmacol Biol Psychiatry 50 2014 143 150
19. M.E. Frizzo, D.R. Lara, S. Prokopiuk Ade, C.R. Vargas, C.G. Salbego, and M. Wajner Guanosine enhances glutamate uptake in brain cortical slices at normal and excitotoxic conditions Cell Mol Neurobiol 22 2002 353 363
20. P. Galecki, J. Szemraj, M. Bienkiewicz, K. Zboralski, and E. Galecka Oxidative stress parameters after combined fluoxetine and acetylsalicylic acid therapy in depressive patients Hum Psychopharmacol 24 2009 277 286
21. J.W. Gawryluk, J.F. Wang, A.C. Andreazza, L. Shao, and L.T. Young Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders Int J Neuropsychopharmacol 14 2011 123 130
22. B.P. Godsil, J.P. Kiss, M. Spedding, and T.M. Jay The hippocampal-prefrontal pathway: the weak link in psychiatric disorders? Eur Neuropsychopharmacol 23 2013 1165 1181
23. B. Halliwell Biochemistry of oxidative stress Biochem Soc Trans 35 2007 1147 1150
24. G.E. Hardingham, Y. Fukunaga, and H. Bading Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways Nat Neurosci 5 2002 405 414
25. H. Herken, A. Gurel, S. Selek, F. Armutcu, M.E. Ozen, and M. Bulut Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment Arch Med Res 38 2007 247 252
26. J.P. Herman, and W.E. Cullinan Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis Trends Neurosci 20 1997 78 84
27. I. Hovatta, J. Juhila, and J. Donner Oxidative stress in anxiety and comorbid disorders Neurosci Res 68 2010 261 275
28. A. Ishikawa, and S. Nakamura Convergence and interaction of hippocampal and amygdalar projections within the prefrontal cortex in the rat J Neurosci 23 2003 9987 9995
29. N. Katalinic, R. Lai, A. Somogyi, P.B. Mitchell, P. Glue, and C.K. Loo Ketamine as a new treatment for depression: a review of its efficacy and adverse effects Aust N Z J Psychiatry 47 2013 710 727
30. L. Khalaj, S. Chavoshi Nejad, M. Mohammadi, S. Sarraf Zadeh, M. Hossein Pour, and A. Ahmadiani Gemfibrozil pretreatment proved protection against acute restraint stress-induced changes in the male rats' hippocampus Brain Res 1527 2013 117 130
31. S.D. Khanzode, G.N. Dakhale, S.S. Khanzode, A. Saoji, and R. Palasodkar Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors Redox Rep 8 2003 365 370
32. 1H-MRS study at 4.7 T Neurochem Res 37 2012 740 748
33. M.F. Knapen, P.L. Zusterzeel, W.H. Peters, and E.A. Steegers Glutathione and glutathione-related enzymes in reproduction. A review Eur J Obstet Gynecol Reprod Biol 82 1999 171 184
34. J. Kodydkova, L. Vavrova, M. Zeman, R. Jirak, J. Macasek, and B. Stankova Antioxidative enzymes and increased oxidative stress in depressive women Clin Biochem 42 2009 1368 1374
35. V.O. Kotan, E. Sarandol, E. Kirhan, G. Ozkaya, and S. Kirli Effects of long-term antidepressant treatment on oxidative status in major depressive disorder: a 24-week follow-up study Prog Neuropsychopharmacol Biol Psychiatry 35 2011 1284 1290
36. V. Krishnan, and E.J. Nestler The molecular neurobiology of depression Nature 455 2008 894 902
37. A. Kumar, R. Garg, and A.K. Prakash Effect of St. John's Wort (Hypericum perforatum) treatment on restraint stress-induced behavioral and biochemical alteration in mice BMC Complement Altern Med 10 2010 18
38. S.Y. Lee, S.J. Lee, C. Han, A.A. Patkar, P.S. Masand, and C.U. Pae Oxidative/nitrosative stress and antidepressants: targets for novel antidepressants Prog Neuropsychopharmacol Biol Psychiatry 46 2013 224 235
39. K.R. Lobato, C.C. Cardoso, R.W. Binfare, J. Budni, C.L. Wagner, and P.S. Brocardo alpha-Tocopherol administration produces an antidepressant-like effect in predictive animal models of depression Behav Brain Res 209 2010 249 259
40. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J Biol Chem 193 1951 265 275
41. M.T. Lowy, L. Wittenberg, and B.K. Yamamoto Effect of acute stress on hippocampal glutamate levels and spectrin proteolysis in young and aged rats J Neurochem 65 1995 268 274
42. M. Maes, I. Mihaylova, M. Kubera, M. Uytterhoeven, N. Vrydags, and E. Bosmans Increased plasma peroxides and serum oxidized low density lipoprotein antibodies in major depression: markers that further explain the higher incidence of neurodegeneration and coronary artery disease J Affect Disord 125 2010 287 294
43. M. Maes, P. Galecki, Y.S. Chang, and M. Berk A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness Prog Neuropsychopharmacol Biol Psychiatry 35 2011 676 692
44. M. Maes, I. Mihaylova, M. Kubera, M. Uytterhoeven, N. Vrydags, and E. Bosmans Lower whole blood glutathione peroxidase (GPX) activity in depression, but not in myalgic encephalomyelitis/chronic fatigue syndrome: another pathway that may be associated with coronary artery disease and neuroprogression in depression Neuro Endocrinol Lett 32 2011 133 140
45. M.P. Mattson Glutamate and neurotrophic factors in neuronal plasticity and disease Ann N Y Acad Sci 1144 2008 97 112
46. B.S. McEwen Stress and hippocampal plasticity Annu Rev Neurosci 22 1999 105 122
47. B.S. McEwen Effects of adverse experiences for brain structure and function Biol Psychiatry 48 2000 721 731
48. B.S. McEwen Glucocorticoids, depression, and mood disorders: structural remodeling in the brain Metabolism 54 2005 20 23
49. L.A. Mendez-Cuesta, B. Marquez-Valadez, V. Perez-De la Cruz, P.D. Maldonado, R.A. Santana, and C. Escobar-Briones Early changes in oxidative stress markers in a rat model of acute stress: effect of l-carnitine on the striatum Basic Clin Pharmacol Toxicol 109 2011 123 129
50. C.A. Michalakeas, J.T. Parissis, A. Douzenis, M. Nikolaou, C. Varounis, and I. Andreadou Effects of sertraline on circulating markers of oxidative stress in depressed patients with chronic heart failure: a pilot study J Card Fail 17 2011 748 754
51. H.P. Misra, and I. Fridovich The purification and properties of superoxide dismutase from Neurospora crassa J Biol Chem 247 1972 3410 3414
52. M. Moretti, J. Budni, D.B. Dos Santos, A. Antunes, J.F. Daufenbach, and L.M. Manosso Protective effects of ascorbic acid on behavior and oxidative status of restraint-stressed mice J Mol Neurosci 49 2013 68 79
53. L. Musazzi, M. Milanese, P. Farisello, S. Zappettini, D. Tardito, and V.S. Barbiero Acute stress increases depolarization-evoked glutamate release in the rat prefrontal/frontal cortex: the dampening action of antidepressants PLoS One 5 2010 e8566
54. M.J. Niciu, D.F. Ionescu, E.M. Richards, and C.A. Zarate Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder J Neural Transm 121 2014 907 924
55. H. Ohkawa, N. Ohishi, and K. Yagi Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Anal Biochem 95 1979 351 358
56. M.E. Ozcan, M. Gulec, E. Ozerol, R. Polat, and O. Akyol Antioxidant enzyme activities and oxidative stress in affective disorders Int Clin Psychopharmacol 19 2004 89 95
57. S.B. Patten, J.L. Wang, J.V. Williams, S. Currie, C.A. Beck, and C.J. Maxwell Descriptive epidemiology of major depression in Canada Can J Psychiatry 51 2006 84 90
58. E.S. Paykel Life events and affective disorders Acta Psychiatr Scand Suppl 2003 61 66
59. F. Petronilho, S.R. Perico, F. Vuolo, F. Mina, L. Constantino, and C.M. Comim Protective effects of guanosine against sepsis-induced damage in rat brain and cognitive impairment Brain Behav Immun 26 2012 904 910
60. R.D. Porsolt, A. Bertin, and M. Jalfre Behavioral despair in mice: a primary screening test for antidepressants Arch Int Pharmacodyn Ther 229 1977 327 336
61. J.L. Price, and W.C. Drevets Neurocircuitry of mood disorders Neuropsychopharmacology 35 2010 192 216
62. I.J. Reynolds, and T.G. Hastings Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptor activation J Neurosci 15 1995 3318 3327
63. J.M. Rosa, A.L. Dafre, and A.L. Rodrigues Antidepressant-like responses in the forced swimming test elicited by glutathione and redox modulation Behav Brain Res 253 2013 165 172
64. J. Rybka, K. Kedziora-Kornatowska, P. Banas-Lezanska, I. Majsterek, L.A. Carvalho, and A. Cattaneo Interplay between the pro-oxidant and antioxidant systems and proinflammatory cytokine levels, in relation to iron metabolism and the erythron in depression Free Radic Biol Med 63 2013 187 194
65. A. Sarandol, E. Sarandol, S.S. Eker, S. Erdinc, E. Vatansever, and S. Kirli Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems Hum Psychopharmacol 22 2007 67 73
66. E. Satoh, and S. Shimeki Acute restraint stress enhances calcium mobilization and glutamate exocytosis in cerebrocortical synaptosomes from mice Neurochem Res 35 2010 693 701
67. G. Scapagnini, S. Davinelli, F. Drago, A. De Lorenzo, and G. Oriani Antioxidants as antidepressants fact or fiction? CNS Drugs 26 2012 477 490
68. A.P. Schmidt, A.E. Böhmer, C. Schallenberger, C. Antunes, R.G. Tavares, and S.T. Wofchuk Mechanisms involved in the antinociception induced by systemic administration of guanosine in mice Br J Pharmacol 159 2010 1247 1263
69. J.S. Seo, J.Y. Park, J. Choi, T.K. Kim, J.H. Shin, and J.K. Lee NADPH oxidase mediates depressive behavior induced by chronic stress in mice J Neurosci 32 2012 9690 9699
70. V. Srinivasan, D. De Berardis, S.D. Shillcutt, and A. Brzezinski Role of melatonin in mood disorders and the antidepressant effects of agomelatine Expert Opin Investig Drugs 21 2012 1503 1522
71. A. Tarozzi, A. Merlicco, F. Morroni, C. Bolondi, P. Di Iorio, and R. Ciccarelli Guanosine protects human neuroblastoma cells from oxidative stress and toxicity induced by amyloid-beta peptide oligomers J Biol Regul Homeost Agents 24 2010 297 306
72. D. Trotti, N.C. Danbolt, and A. Volterra Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration? Trends Pharmacol Sci 19 1998 328 334
73. H. Tsuboi, A. Tatsumi, K. Yamamoto, F. Kobayashi, K. Shimoi, and N. Kinae Possible connections among job stress, depressive symptoms, lipid modulation and antioxidants J Affect Disord 91 2006 63 70
74. S. Turkseven, A. Kruger, C.J. Mingone, P. Kaminski, M. Inaba, and L.F. Rodella Antioxidant mechanism of heme oxygenase-1 involves an increase in superoxide dismutase and catalase in experimental diabetes Am J Physiol Heart Circ Physiol 289 2005 H701 H707
75. J.F. Turrens Mitochondrial formation of reactive oxygen species J Physiol 552 2003 335 344
76. M. Valko, D. Leibfritz, J. Moncol, M.T. Cronin, M. Mazur, and J. Telser Free radicals and antioxidants in normal physiological functions and human disease Int J Biochem Cell Biol 39 2007 44 84
77. E.R. Vinade, A.P. Schmidt, M.E. Frizzo, L.V. Portela, F.A. Soares, and F.D. Schwalm Effects of chronic administered guanosine on behavioral parameters and brain glutamate uptake in rats J Neurosci Res 79 2005 248 253
78. A. Wendel Glutathione peroxidase Methods Enzymol 77 1981 325 333
79. C.A. Zarate Jr., J.B. Singh, P.J. Carlson, N.E. Brutsche, R. Ameli, and D.A. Luckenbaugh A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression Arch Gen Psychiatry 63 2006 856 864
80. C. Zarate Jr., R. Machado-Vieira, I. Henter, L. Ibrahim, N. Diazgranados, and G. Salvadore Glutamatergic modulators: the future of treating mood disorders? Harv Rev Psychiatry 18 2010 293 303
81. X.Y. Zhang, and J.K. Yao Oxidative stress and therapeutic implications in psychiatric disorders Prog Neuropsychopharmacol Biol Psychiatry 46 2013 197 199